GPR52 agonists (Beacon Discovery/Boehringer Ingelheim Pharma)

N/A

Report date: 2025/03/20 14:53:24
NME

Base Information

Drug NameGPR52 agonists (Beacon Discovery/Boehringer Ingelheim Pharma)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProbable G-protein coupled receptor 52 agonists
TargetsProbable G-protein coupled receptor 52
Therapy Area/IndicationsPsychotic DisordersCognition Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBeacon Discovery Inc
China Registration ClassN/A

Develop Information

Active CompaniesBeacon Discovery IncBoehringer Ingelheim Pharma Gmbh & Co Kg
Inactive CompaniesN/A
Active IndicationsPsychotic DisordersCognition Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A